| Drug Name |
Aminolevulinic acid hydrochloride |
| Drug ID |
BADD_D00111 |
| Description |
A compound produced from succinyl-CoA and glycine as an intermediate in heme synthesis. It is used as a photochemotherapy for actinic keratosis. [PubChem] |
| Indications and Usage |
Aminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp. |
| Marketing Status |
approved |
| ATC Code |
L01XD04 |
| DrugBank ID |
DB00855
|
| KEGG ID |
D02908
|
| MeSH ID |
D000622
|
| PubChem ID |
123608
|
| TTD Drug ID |
D0O4GY
|
| NDC Product Code |
67308-101; 70621-101; 59137-231; 71956-001 |
| UNII |
V35KBM8JGR
|
| Synonyms |
Aminolevulinic Acid | Acid, Aminolevulinic | Delta-Aminolevulinic Acid | Acid, Delta-Aminolevulinic | Delta Aminolevulinic Acid | Levulan | 5-Aminolaevulinate | 5 Aminolaevulinate | 5-Aminolevulinate | 5 Aminolevulinate | Aminolevulinic Acid Hydrochloride | Acid Hydrochloride, Aminolevulinic | Hydrochloride, Aminolevulinic Acid |
